Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
2017
250 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
27.86
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal | Researchclopedia
·
Institut Claudius Regaud
Samuel Ejadi
·
Pinnacle Oncology Hematology
Mark N. Stein
·
Rutgers, The State University of New Jersey
Emily Chan
·
Vanderbilt-Ingram Cancer Center
Matteo Simonelli
·
Humanitas University
Anne Morosky
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Sanatan Saraf
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Kenneth Emancipator
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Minori Koshiji
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Jaafar Bennouna
·
Institut de Cancérologie de l'Ouest